Literature DB >> 941300

The pathogenicity of Mycobacterium fortuitum and Mycobacterium chelonei in man: a report of seven cases.

R B Dreisin, C Scoggin, P T Davidson.   

Abstract

The clinical records of 7 patients referred to the National Jewish Hospital and Research Center over a 6-year period for evaluation of an abnormal chest x-ray and repeated sputum isolates of rapidly growing mycobacteria (Runyon's Group IV) were reviewed to determine the potential pathogenicity of these organisms. Mycobacterium fortuitum was isolated from 5 patients and Mycobacterium chelonei from 2. Haemoptysis, cough and weight loss were prominent in 6. Three had rheumatoid arthritis. Although two demonstrated cutaneous anergy, lymphocyte responsiveness to PHA was normal. PPD-F was not useful in skin testing or in the in vitro evaluation of lymphocyte function. Histologic examination of the lungs of 2 patients demonstrated caseating granulomata. One patient died of massive pulmonary haemorrhage soon after intiation of therapy. Multi-drug treatment regimens generally resulted in progressive sterilization of the sutum and improvement in the appearance of the chest x-ray. We conclude that some rapidly growing mycobacteria can cause potentially fatal cavitary lung disease and that intensive anti-tuberculosis therapy may successfully alter its course.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 941300     DOI: 10.1016/0041-3879(76)90017-9

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  10 in total

1.  Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents.

Authors:  W E Sanders; E C Hartwig; N J Schneider; R Cacciatore; H Valdez
Journal:  Antimicrob Agents Chemother       Date:  1977-08       Impact factor: 5.191

2.  Fatal pulmonary infection with Mycobacterium fortuitum.

Authors:  J M Nussbaum; P N Heseltine
Journal:  West J Med       Date:  1990-04

3.  Isolation of Mycobacterium chelonei from a granulomatous lesion in a pig.

Authors:  C O Thoen; E M Himes
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

4.  Disseminated Mycobacterium chelonae infection presenting as progressive multifocal osteomyelitis: Report of two cases and a review of the literature.

Authors:  D A Oelberg; J Mendelson; M A Miller; A Dascal
Journal:  Can J Infect Dis       Date:  1994-01

5.  Isolation of Mycobacterium chelonei with the lysis-centrifugation blood culture technique.

Authors:  M F Fojtasek; M T Kelly
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

6.  Prosthetic valve endocarditis due to Mycobacterium fortuitum.

Authors:  S L Narasimhan; T W Austin
Journal:  Can Med Assoc J       Date:  1978-07-22       Impact factor: 8.262

7.  Detection of Mycobacterium tuberculosis group organisms in human and mouse joint tissue by reverse transcriptase PCR: prevalence in diseased synovial tissue suggests lack of specific association with rheumatoid arthritis.

Authors:  K E Kempsell; C J Cox; A A McColm; J A Bagshaw; R Reece; D J Veale; P Emery; J D Isaacs; J S Gaston; J S Crowe
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients.

Authors:  K Jacobson; R Garcia; H Libshitz; E Whimbey; K Rolston; D Abi-Said; I Raad
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-09       Impact factor: 3.267

9.  Antimicrobial susceptibility testing of Mycobacterium fortuitum complex.

Authors:  D F Welch; M T Kelly
Journal:  Antimicrob Agents Chemother       Date:  1979-06       Impact factor: 5.191

10.  Molecular species of mycolic acid subclasses in eight strains of Mycobacterium smegmatis.

Authors:  T Baba; K Kaneda; E Kusunose; M Kusunose; I Yano
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.